Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities: 2011-2025

Historic Cash from Investing Activities for Catalyst Pharmaceuticals (CPRX) over the last 10 years, with Jun 2025 value amounting to -$26,000.

  • Catalyst Pharmaceuticals' Cash from Investing Activities fell 160.00% to -$26,000 in Q2 2025 from the same period last year, while for Jun 2025 it was -$383,000, marking a year-over-year increase of 99.71%. This contributed to the annual value of -$556,000 for FY2024, which is 99.81% up from last year.
  • Latest data reveals that Catalyst Pharmaceuticals reported Cash from Investing Activities of -$26,000 as of Q2 2025, which was up 70.45% from -$88,000 recorded in Q4 2024.
  • In the past 5 years, Catalyst Pharmaceuticals' Cash from Investing Activities ranged from a high of -$10,000 in Q2 2024 and a low of -$162.4 million during Q1 2023.
  • For the 3-year period, Catalyst Pharmaceuticals' Cash from Investing Activities averaged around -$36.8 million, with its median value being -$229,000 (2024).
  • In the last 5 years, Catalyst Pharmaceuticals' Cash from Investing Activities tumbled by 70,215.91% in 2023 and then surged by 99.88% in 2024.
  • Over the past 5 years, Catalyst Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at -$41,000 in 2021, then crashed by 94.12% to -$132,000 in 2022, then plummeted by 70,215.91% to -$38.3 million in 2023, then surged by 99.77% to -$88,000 in 2024, then crashed by 160.00% to -$26,000 in 2025.
  • Its Cash from Investing Activities stands at -$26,000 for Q2 2025, versus -$88,000 for Q4 2024 and -$259,000 for Q3 2024.